Details
Description
The goal of this analysis was to describe COVID-19 therapeutic treatment and death among patients who were hospitalized with COVID-19 and among patients with severe COVID-19, stratified by racial and ethnic group in the TriNetX platform. In addition to describing these groups overall, we also described the subset of each group with evidence of vaccination against COVID-19.
This analysis contains four reports:
- Report 1: The study period includes data from January 1, 2021 to April 30, 2021 and contains data from 36 health care organizations (HCOs), provided through the TriNetX Live™ platform in their USA Network. The query was run on June 21, 2022.
- Report 2: The study period includes data from May 1, 2021 to August 31, 2021 and contains data from 36 HCOs, provided through the TriNetX Live™ platform in their USA Network. The query was run on June 13, 2022.
- Report 3: The study period includes data from September 1, 2021 to December 31, 2021 and contains data from 36 HCOs, provided through the TriNetX Live™ platform in their USA Network. The query was run on June 30, 2022.
- Report 4: The study period includes data from January 1, 2022 to April 30, 2022 and contains data from 36 HCOs, provided through the TriNetX Live™ platform in their USA Network. The query was run on July 12, 2022.
Deliverables (4)
Sentinel Modular Program Report: Racial and Ethnic Differences in COVID-19 Treatment and Mortality in TriNetX: A Descriptive Analysis, Report 1
Sentinel Modular Program Report: Racial and Ethnic Differences in COVID-19 Treatment and Mortality in TriNetX: A Descriptive Analysis, Report 2
Sentinel Modular Program Report: Racial and Ethnic Differences in COVID-19 Treatment and Mortality in TriNetX: A Descriptive Analysis, Report 3
Sentinel Modular Program Report: Racial and Ethnic Differences in COVID-19 Treatment and Mortality in TriNetX: A Descriptive Analysis, Report 4